Article
Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis.
BMJ (Clinical research ed.) - 25 May 1991
Ranieri E, Ryall R G, Morris C P, Nelson P V, Carey W F, Pollard A C, Robertson E F
Abstract excerpt
OBJECTIVE: To assess the effectiveness of a two tier neonatal screening strategy for cystic fibrosis, which combines estimation of immunoreactive trypsinogen followed by direct gene analysis in dried blood spot samples collected at age 5 days. DESIGN: Prospective study of two tier screening strategy. The first tier of testing immunoreactive trypsinogen concentration was measured in dried blood spot samples from...
Topics
- Cystic Fibrosis
- DNA Mutational Analysis
- Female
- Humans
- Infant, Newborn
- Male
- Mutation
- Neonatal Screening
- Prospective Studies
- South Australia
- Trypsinogen
